Corient Private Wealth
BIOA

Corient Private Wealth’s BioAge Labs BIOA Stock Holding History

Corient Private Wealth’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389K Buy
+22,782
New +$439K ﹤0.01% 2169

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Corient Private Wealth's BIOA Position: Q1 2026 in Review

Corient Private Wealth opened a new position in BioAge Labs (BIOA) in Q1 2026: 22,782 shares worth $389K. The stake represents ﹤0.01% of the portfolio and ranks #2169 among its holdings.

144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Corient Private Wealth held 22,782 shares of BioAge Labs worth $389K as of Q1 2026.
  • BioAge Labs was a new Corient Private Wealth position in Q1 2026.
  • BioAge Labs made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2169 holding.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.